
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
CDW reports before market open, meaning Day 0 captures the market's immediate reaction during the first trading session after results are released, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-06 | -$27.80 (-20.32%) | $22.35 (16.34%) | +$1.20 (+1.10%) | $5.27 (4.83%) |
| 2026-02-04 | +$11.92 (+9.45%) | $10.89 (8.63%) | +$2.69 (+1.95%) | $5.15 (3.73%) |
| 2025-11-04 | -$13.17 (-8.51%) | $16.76 (10.82%) | +$4.66 (+3.29%) | $5.57 (3.93%) |
| 2025-08-06 | +$0.27 (+0.16%) | $10.31 (6.24%) | -$3.63 (-2.19%) | $6.75 (4.08%) |
| 2025-05-07 | +$11.59 (+7.07%) | $14.82 (9.04%) | +$4.57 (+2.60%) | $5.49 (3.13%) |
| 2025-02-05 | +$6.79 (+3.41%) | $19.41 (9.74%) | -$6.27 (-3.04%) | $6.83 (3.31%) |
| 2024-10-30 | -$24.84 (-11.30%) | $16.49 (7.50%) | -$6.83 (-3.50%) | $6.46 (3.31%) |
| 2024-07-31 | -$14.36 (-6.18%) | $7.46 (3.21%) | -$4.52 (-2.07%) | $8.24 (3.78%) |
| Avg Abs Move | 8.30% | 8.94% | 2.47% | 3.76% |
CDW's post-earnings price behavior has been notably volatile, with an average absolute Day 0 move of 8.30% and historical moves ranging from a 20.32% decline to an 11.30% drop on the downside, and gains as high as 9.45% on the upside. The most recent earnings report (Q1 2026) produced the largest negative reaction in the dataset, with a -20.32% Day 0 plunge that underscores how severely the market punished the modest earnings miss.
The historical pattern shows CDW is capable of significant moves in either direction, with five of the last eight reports producing Day 0 moves exceeding 6% in absolute terms. Day +1 follow-through has been more muted, averaging 2.47%, suggesting most of the price discovery occurs in the immediate reaction. The average Day 0 range of 8.94% indicates substantial intraday volatility as investors digest results and management commentary.
Investors should prepare for meaningful price movement, particularly given the heightened sensitivity demonstrated in Q1's reaction. The stock's recent technical strength and positioning above all moving averages could amplify moves in either direction, with a strong beat potentially triggering a relief rally and any disappointment risking another sharp decline.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 17) |
| Expected Move | $17.04 (11.07%) |
| Expected Range | $136.96 to $171.04 |
| Implied Volatility | 65.22% |
The options market is pricing an expected move of 11.07% for the August 21 expiration, which is notably higher than CDW's average historical Day 0 move of 8.30%. This elevated implied volatility suggests options traders are anticipating above-average price movement, likely reflecting lingering uncertainty following the Q1 earnings disaster and the stock's subsequent 20%+ decline.
Analysts maintain a bullish stance on CDW with an average rating of 4.18 out of 5.0, firmly in buy territory. The current consensus includes 6 Strong Buy ratings, 1 Moderate Buy, and 4 Hold ratings, with no sell recommendations. This positive tilt reflects confidence in CDW's market position and long-term growth prospects despite recent execution challenges.
The analyst community has maintained a stable outlook, with sentiment classified as unchanged over the past month. The consistency in ratings suggests analysts view Q1's disappointment as a temporary setback rather than a fundamental deterioration in the business model. The average price target of $152.80 implies modest upside from the current price of $154.00, though the range of targets is wide, spanning from a low of $123.00 to a high of $175.00.
The relatively tight clustering around current levels in the average target suggests analysts believe the stock is fairly valued at present levels, with the bull case (represented by the $175.00 high target) offering 13.6% upside and the bear case ($123.00 low target) implying 20.1% downside risk. This asymmetric risk-reward profile heading into earnings reflects both the potential for a strong recovery if execution improves and the vulnerability to further downside if operational challenges persist.
CDW enters earnings with strong technical momentum, as the Barchart Technical Opinion has surged to an 88% Buy signal, up dramatically from 72% just one week ago and 24% a month ago. This rapid improvement in technical sentiment reflects the stock's powerful recovery from the Q1 earnings selloff, with shares climbing above all key moving averages and establishing a clear uptrend.
Timeframe Analysis:
Trend Characteristics: The combination of Strong strength and Strongest direction indicates CDW is in a robust uptrend with powerful momentum heading into the earnings release.
The stock is trading at $154.00, positioned above all major moving averages: the 5-day ($148.60), 10-day ($141.89), 20-day ($139.16), 50-day ($133.90), 100-day ($127.79), and 200-day ($132.84). This alignment with all moving averages sloping upward represents a textbook bullish technical setup, often called a "golden cross" environment when shorter-term averages are above longer-term ones.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $148.60 | 50-Day MA | $133.90 |
| 10-Day MA | $141.89 | 100-Day MA | $127.79 |
| 20-Day MA | $139.16 | 200-Day MA | $132.84 |
The technical picture is decidedly supportive heading into earnings, with the stock having reclaimed all major moving averages and momentum indicators flashing maximum bullish readings in the short and medium term. The 16% rally from the 50-day moving average to current levels demonstrates strong buying interest and suggests investors are positioning for a positive surprise. However, the elevated options-implied move of 11.07% and the stock's extended position above near-term moving averages also create vulnerability to profit-taking if results disappoint. Key support now sits at the 20-day moving average around $139, while a strong earnings beat could target the analyst high price target of $175, representing 13.6% upside from current levels.